Annotated genes from all three SLE-co-localised CpG sites were IFN-regulated, with FLI1 being type II IFN-regulated and ZMYND15, MICB and HLA-B being both type I and type II IFN-regulated. The gene discussed is FLI1; the disease is systemic lupus erythematosus.